References
- Lundberg J M, Terenius L., Hökfelt T. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116: 477–80
- Lundbiad L., Änggard A., Saria A., Lundberg JM. Neuropeptide Y (NPY) and non-adrenergicsympathetic vascular control of the cat nasal mucosa. J Auton Nerv Syst 1987; 20: 189–97
- Lacroix JS., Änggard A., Hokfelt T., O'Hare M MT, Fahrenkrug J, Lundberg J, Neuropeptide M. Y. presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tiss Res 1990; 259: 119–28
- Ekblad E, Edvinsson Wahlestedt L., Uddman C. R., Håkanson R., Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept 1984; 8: 225–35
- Lacroix J, Stjärne S. P., Änggård A, Lundberg JM. Sympathetic vascular control of the pig nasal mucosa (2): reserpine-resistant. non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol Scand 1988; 133: 183–97
- Edvinsson L., Ekblad E., Hakanson R., Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984; 83: 519–25
- Matran R., Martling C-R., Lundberg JM. Inhibition of cholinergic and non-adrenergic non-cholinergic bronchoconstriction in the guinea pig mediated by neuropeptide Y and α2-adrenoceptors and opiate receptors. Eur J Pharmacol 1989; 163: 15–23
- Edvinsson L., McCulloch P., Emson J., Tatemoto K, Uddman R. Neuropeptide Y: Cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett 1983; 43: 79–84
- Lundberg J, Hemsen M. A, Larsson O., Rudehill A, Saria A, Fredholm BB. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol 1988; 145: 21–29
- Lacroix J, Stjärne S. P., Änggard A., Lundberg JM. Sympathetic vascular control of the pig nasal mucosa (111): co-release of noradrenaline and neuropeptide Y. Acta Physiol Scand 1989; 135: 17–28
- Hybbinette J C, Mercke U. Effects of sympathomimetic agonists and antagonists on mucociliary activity. Acta Otolaryngol (Stockh) 1982; 94: 121–30
- Cervin A, Bende M, Lindberg S., Mercke U., Olsson P. Relations between blood flow and mucociliary activity in the rabbit maxillary sinus. Acta Otolaryngol (Stockh) 1988; 105: 350–6
- Hybbinette J-C, Mercke U. A method for evaluating the effect of pharmacological substances on mucociliary activity in vivo. Acta Otolaryngol (Stockh) 1982; 93: 151–9
- Mercke U., Hakansson CH., Toremalm NG. A method for standardized studies of mucociliary activity. Acta Otolaryngol (Stockh) 1974; 78: 118–23
- O'Hare M MT, Tenmoku S, Aakerlund L, Hilsted L, Johnsen A, Schwartz TW. Neuropeptide Y in guinea pig, rabbit, rat and man. Identical amino acid sequence and oxidation of methionine-17. Regul Pept 1988; 20: 293–304
- Lenox R, Ellis H. J, Van Riper D, Ehrlich YH. Alpha2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve. Mol Pharmacol 1985; 27: 1–9
- Noda Y., Yamaki K., Takagi K., Satake T. Effects of dibutyryl cyclic adenosine monophosphate and colforsin on mucociliary transport using frog palate. Arzneimittelforsch/Drug Res 1987; 37: 822–5
- Tamaoki J, Kondo M, Takizawa T. Effect of cAMP on ciliary function in rabbit tracheal epithelial cells. J Appl Physiol 1989; 66: 1035–9
- Nickerson M, Collier B. Drugs inhibiting adrenergic nerves and structures innervated by them. The pharmacological basis of therapeutics, LS. Goodman, AG Gillman. Macmillan, New York 1975; 543–3
- Lundberg J, Tatemoto M. K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to a-adrenoceptor blockade. Acta Physiol Scand 1982; 116: 393–402
- Pernow J, Svenberg T, Lundberg JM. Actions of calcium antagonists on pre-and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro. Eur J Pharmacol 1987; 136: 207–18